mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
6e-06 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |